Extracellular Vesicles as Emerging Drug Delivery Platforms in Triple-Negative Breast Cancer: A Systematic Review.

Tian J, Chin YZ, Ng MH, Pang KL, Law JX

Open source

DOI
10.2147/ijn.s570252
Published
2026
Container
International journal of nanomedicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ijn.s570252,
  title = {Extracellular Vesicles as Emerging Drug Delivery Platforms in Triple-Negative Breast Cancer: A Systematic Review.},
  author = {Tian J and Chin YZ and Ng MH and Pang KL and Law JX},
  year = {2026},
  journal = {International journal of nanomedicine},
  doi = {10.2147/ijn.s570252},
  url = {https://doi.org/10.2147/ijn.s570252}
}

RIS

TY  - JOUR
TI  - Extracellular Vesicles as Emerging Drug Delivery Platforms in Triple-Negative Breast Cancer: A Systematic Review.
AU  - Tian J
AU  - Chin YZ
AU  - Ng MH
AU  - Pang KL
AU  - Law JX
PY  - 2026
JO  - International journal of nanomedicine
DO  - 10.2147/ijn.s570252
UR  - https://doi.org/10.2147/ijn.s570252
ER  - 

APA

J, T., YZ, C., MH, N., KL, P., & JX, L. (2026). Extracellular Vesicles as Emerging Drug Delivery Platforms in Triple-Negative Breast Cancer: A Systematic Review.. International journal of nanomedicine. https://doi.org/10.2147/ijn.s570252

Source records